IPRIPR2026-00313Trial Instituted
Merck Sharp & Dohme LLCv.Halozyme, Inc. et al.
IPR challenge of US 11041149.
Type
IPR
Filed
Mar 23, 2026
Instituted
Sep 9, 2026
Decided
Sep 9, 2026
Patent
Application
16824572
Inventor
Ge WEI et al
Granted
Jun 22, 2021
01
Timeline
2 milestones
2026-03-23Petition filed
2026-09-09Institution
02
Parties & counsel
Petitioner
Merck Sharp & Dohme LLC
Counsel
KUSHAN, JEFFREYet al
Patent Owner
Halozyme, Inc. et al.
Counsel
Ellison, Eldoraet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →